A critical gap exists in cancer care where cardiovascular risk factors are often ignored. As cancer treatments improve survival, patients are increasingly dying from preventable heart attacks and strokes, necessitating the specialized field of cardio-oncology.

HDL cholesterol, typically seen as protective, can become dysfunctional in the presence of risk factors like smoking or obesity. This dysfunctional HDL then contributes to atherosclerosis instead of preventing it, challenging the simplistic 'good vs. bad' cholesterol narrative.

Many chronic illnesses, including high blood pressure, cancer, and cognitive decline, are not separate issues but symptoms of a single underlying problem: chronically elevated insulin levels. This metabolic “trash” accumulates over years, making the body a breeding ground for disease.

A 7-year study of healthy individuals over 85 found minimal genetic differences from their less healthy counterparts. The key to their extreme healthspan appears to be a robust immune system, which is significantly shaped by lifestyle choices, challenging the common narrative about being born with "good genes."

Chronic illnesses like cancer, heart disease, and Alzheimer's typically develop over two decades before symptoms appear. This long "runway" is a massive, underutilized opportunity to identify high-risk individuals and intervene, yet medicine typically focuses on treatment only after a disease is established.

The silent nature of high cholesterol creates a psychological barrier. Patients who feel perfectly healthy are often unwilling to commit to lifelong treatment, even when their risk is high, leading to preventable cardiovascular events.

The body endogenously produces all the cholesterol necessary for vital functions. Optimal LDL levels are around 40 mg/dL, similar to a newborn's. Higher levels, typically from diet, are not needed and function like a toxin, initiating atherosclerosis.

Universal cholesterol screening in young children acts as a trigger for cascade screening, where parents (often in their 30s) and grandparents (50s) are also tested. This uncovers and allows for treatment of familial hypercholesterolemia across three generations from a single pediatric test.

Despite the emphasis on genes from the Human Genome Project era, large-scale modern studies show genetics determine only about 7% of how long you live. The remaining 93% is attributable to lifestyle, environment, and other non-genetic factors, giving individuals immense agency over their lifespan.